Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Cogstate Limited

Market Cap 47Cr 33Cr 28Cr 26Cr 25Cr 46Cr 3.13TCr 310.04Cr 120.78Cr 1.53TCr 124.08Cr 121.45Cr 5.3TCr P/E 2026 *
27.8x
P/E 2027 * 22.3x
Enterprise Value 41Cr 29Cr 25Cr 23Cr 22Cr 40Cr 2.73TCr 271.26Cr 105.68Cr 1.34TCr 108.56Cr 106.25Cr 4.64TCr EV / Sales 2026 *
4.86x
EV / Sales 2027 * 4.12x
Free-Float
54.16%
Yield 2026 *
1.12%
Yield 2027 * 1.5%

Last Transcript: Cogstate Limited

1 day-0.73%
1 week-2.15%
Current month+7.06%
1 month+8.76%
3 months+26.98%
6 months+21.33%
Current year+20.80%
1 week 2.7
Extreme 2.705
2.91
1 month 2.36
Extreme 2.36
2.91
Current year 2.01
Extreme 2.01
2.91
1 year 1.35
Extreme 1.35
2.97
3 years 0.8
Extreme 0.795
2.97
5 years 0.8
Extreme 0.795
2.97
10 years 0.16
Extreme 0.155
2.97
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/12/1999
Chief Executive Officer - 01/12/2005
Director of Finance/CFO - 01/02/2021
Director TitleAgeSince
Director/Board Member - 01/03/2011
Chairman 67 03/11/2009
Director/Board Member - 20/01/2017
Date Insider Type Main position Quantity % Market Cap.
20/05Buy

Director

430 0.0003%
20/05Buy

Director

3,600 0.0021%
15/04
Myer & Myer Pty Ltd.
BuyCompany 99,74,569 5.8334%
Change 5-day change 1-year change 3-year change Capi.($)
-0.73%-2.15%+90.91%+56.00% 33Cr
-0.41%-1.24%-11.97%-10.24% 4.35TCr
-2.17%+4.70%+293.71%+535.99% 3.33TCr
-1.60%-1.58%-0.19%+31.82% 2.93TCr
+0.44%-3.80%+12.51%-17.06% 2.99TCr
-0.29%+2.65%+13.24%+21.04% 2.54TCr
+3.54%+8.43% - - 1.44TCr
-1.26%-1.11%+53.37%+108.10% 1.32TCr
-1.21%-5.29%+2.18%+3.27% 1.27TCr
-1.18%-2.00%+107.41%+78.18% 1.21TCr
Average -0.26%+1.15%+62.35%+89.68% 2.14TCr
Weighted average by Cap. -0.24%+0.64%+60.17%+104.04%

Financials

2026 *2027 *
Net sales 8.41Cr 5.95Cr 5.12Cr 4.72Cr 4.43Cr 8.32Cr 562.24Cr 56Cr 22Cr 275.33Cr 22Cr 22Cr 954.16Cr 9.61Cr 6.8Cr 5.86Cr 5.4Cr 5.07Cr 9.51Cr 642.99Cr 64Cr 25Cr 314.87Cr 26Cr 25Cr 1.09TCr
Net income 1.66Cr 1.17Cr 1.01Cr 92.99L 87.31L 1.64Cr 110.79Cr 11Cr 4.28Cr 54Cr 4.4Cr 4.3Cr 188.01Cr 2.07Cr 1.47Cr 1.26Cr 1.16Cr 1.09Cr 2.05Cr 138.63Cr 14Cr 5.36Cr 68Cr 5.5Cr 5.39Cr 235.26Cr
Net Debt -5.85Cr -4.14Cr -3.56Cr -3.28Cr -3.08Cr -5.79Cr -391Cr -39Cr -15Cr -191.48Cr -16Cr -15Cr -663.56Cr -7.09Cr -5.02Cr -4.32Cr -3.98Cr -3.74Cr -7.02Cr -474.25Cr -47Cr -18Cr -232.24Cr -19Cr -18Cr -804.84Cr
Logo Cogstate Limited
Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
Employees
160
Date Price Change Volume
17/26/17 2.730 $ -0.73% 27,695
16/26/16 2.750 $ -1.79% 2,53,243
15/26/15 2.800 $ +2.19% 6,76,165
12/26/12 2.740 $ -0.36% 9,17,165
11/26/11 2.750 $ -1.43% 2,51,991
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.750AUD
Average target price
3.175AUD
Spread / Average Target
+15.45%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!